ADIL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 May 2024 @ 16:00):

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders...

Stats
Today's Volume	78 831.00
Average Volume	6.47M
Market Cap	5.72M
EPS	$0 ( 2024-05-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.290
ATR14	$0.0110 (0.77%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Gilliland Robertson H.	Buy	12 000	Stock Option (Right to Buy)
2024-03-25	Newman James W. Jr.	Buy	12 000	Stock Option (Right to Buy)
2024-03-25	Truluck Joseph	Buy	25 000	Stock Option (Right to Buy)
2024-03-25	Claiborne Cary J	Buy	60 000	Stock Option (Right to Buy)
2024-03-25	Anderson J. Kermit	Buy	12 000	Stock Option (Right to Buy)

INSIDER POWER
91.20
Last 98 transactions
Buy: 7 510 922 \| Sell: 1 943 977

Volume Correlation

Long: -0.14 (neutral)

Short: 0.97 (very strong)

Signal:(62.407) Expect same movement, but be aware

Adial Pharmaceuticals Inc Correlation

10 Most Positive Correlations
EXFY	0.967
ELEV	0.966
DRVN	0.965
GSIT	0.964
TSVT	0.963
CMBM	0.958
FGEN	0.956
IPGP	0.956
CMCT	0.952
NNOX	0.951

10 Most Negative Correlations
NVAC	-0.958
PRDO	-0.955
MITA	-0.952
GHIXU	-0.943
WFRD	-0.939
BRIVU	-0.938
MSDA	-0.938
CCRC	-0.935
MMYT	-0.932
DSEY	-0.931

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Adial Pharmaceuticals Inc Correlation - Currency/Commodity

0.54
( weak )

0.00
( neutral )

0.34
( neutral )

Adial Pharmaceuticals Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-564.00 (0.00 %)
EPS:	$-5.44

FY	2023
Revenue:	$0
Gross Profit:	$-564.00 (0.00 %)
EPS:	$-5.44

FY	2022
Revenue:	$0
Gross Profit:	$-60 501.00 (0.00 %)
EPS:	$-317.81

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.971

Financial Reports:

No articles found.

Adial Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.